Pulmonary embolism (PE) is a serious and often deadly condition that can occur without warning. It occurs when a blood clot forms in a vein, usually in the legs, and then travels to the lungs, where it can block the flow of blood and oxygen. This blockage can be life-threatening, and it is not always easy to detect. It is important for doctors to be aware of the risk factors for PE so that they can recognize and treat it quickly and effectively.
Pulmonary embolism (PE) is a condition in which a blood clot forms in a vein, usually in the legs, and then travels to the lungs, where it can block the flow of blood and oxygen. This blockage can be life-threatening, and it is not always easy to detect. The most common symptom of PE is shortness of breath, but other symptoms may include chest pain, coughing up blood, and dizziness.
There are several risk factors that can increase a person’s chances of developing PE. These include: • Age: People over the age of 40 are more likely to develop PE. • Gender: Women are more likely to develop PE than men. • Medical Conditions: People with diabetes, heart disease, or cancer are more likely to develop PE. • Surgery: People who have had surgery, especially orthopedic surgery, are at an increased risk of PE. • Medications: People taking certain medications, such as birth control pills or hormone therapy, are at an increased risk of PE. • Smoking: People who smoke are more likely to develop PE. • Pregnancy: Women who are pregnant are at an increased risk of PE.
In order to diagnose PE, doctors will typically order a chest X-ray, CT scan, or echocardiogram. These tests can help to identify the presence of a blood clot in the lungs. Treatment for PE typically involves the use of blood thinners, such as heparin or warfarin, to reduce the risk of further clots forming. In some cases, surgery may be necessary to remove the clot.
There are several steps that can be taken to reduce the risk of developing PE. These include: • Maintaining a healthy weight. • Exercising regularly. • Avoiding smoking. • Avoiding long periods of inactivity. • Wearing compression stockings. • Taking medications as prescribed.
Pulmonary embolism is a serious and often deadly condition that can occur without warning. It is important for doctors to be aware of the risk factors for PE so that they can recognize and treat it quickly and effectively. By understanding the risk factors and taking steps to reduce them, people can reduce their chances of developing PE.
1.
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma
2.
The Early Progression of Prostate Cancer Is Not Stopped by Metformin.
3.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
4.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
5.
Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.
1.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
2.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
3.
Understanding Iron Saturation Levels in Your Blood
4.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
5.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
3.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
4.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation